4.6 Article

Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma

Qingan Jia et al.

SCIENTIFIC REPORTS (2017)

Article Oncology

Global Cancer Statistics, 2012

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2015)

Editorial Material Cell Biology

Yin and Yang revisited: CCN3 as an anti-fibrotic therapeutic?

Andrew Leask

JOURNAL OF CELL COMMUNICATION AND SIGNALING (2015)

Article Gastroenterology & Hepatology

Hepatocellular carcinoma: clinical frontiers and perspectives

Jordi Bruix et al.

Article Gastroenterology & Hepatology

Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma

Cedric Coulouarn et al.

JOURNAL OF HEPATOLOGY (2014)

Review Gastroenterology & Hepatology

Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever

Vinicio Carloni et al.

LIVER INTERNATIONAL (2014)

Review Gastroenterology & Hepatology

Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma

Virginia Hernandez-Gea et al.

GASTROENTEROLOGY (2013)

Review Cell Biology

CCN proteins: A centralized communication network

Bernard Perbal

JOURNAL OF CELL COMMUNICATION AND SIGNALING (2013)

Review Gastroenterology & Hepatology

Fibrosis-dependent mechanisms of hepatocarcinogenesis

David Y. Zhang et al.

HEPATOLOGY (2012)

Review Biochemistry & Molecular Biology

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

Kai Kessenbrock et al.

Review Oncology

Activation of fibroblasts in cancer stroma

Kati Rasanen et al.

EXPERIMENTAL CELL RESEARCH (2010)

Article Gastroenterology & Hepatology

Hepatocellular carcinoma in cirrhosis: Incidence and risk factors

G Fattovich et al.

GASTROENTEROLOGY (2004)